Capricor Therapeutics (CAPR) Other financing activities (2012 - 2026)

Capricor Therapeutics' Other financing activities history runs 15 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Other financing activities rose 2820.64% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $13.3 million (up 3044.13% YoY), while the FY2025 annual figure was $11.9 million, up 2534.18% from the prior year.
• Other financing activities for Q1 2026 stood at $1.5 million, down from $11.8 million in the prior quarter.
• The five-year high for Other financing activities was $11.8 million in Q4 2025, with the low at $1518.0 in Q3 2022.
• The 5-year median for Other financing activities is $26890.0 (2022), against an average of $988062.4.
• The sharpest annual moves came in 2024 and 2025: Other financing activities soared 8091.48% in 2024, then plunged 94.26% in 2025.
• Capricor Therapeutics' Other financing activities stood at $26315.0 in 2022, then tumbled by 88.5% to $3027.0 in 2023, then jumped by 8091.48% to $247956.0 in 2024, then surged by 4651.44% to $11.8 million in 2025, then sank by 87.52% to $1.5 million in 2026.
• Business Quant data shows CAPR's Other financing activities at $1.5 million in Q1 2026, $11.8 million in Q4 2025, and $6950.0 in Q3 2025.